Trial Profile
Bortezomib + cyclophosphamide + dexamethasone and bortezomib + lenalidomide + dexamethasone in newly diagnosed patients with multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2014
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Millennium
- 25 Sep 2014 New trial record